Vicarious Surgical Inc. financial data

Symbol
RBOT on NYSE, RBOTW on OTC
Location
Waltham, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 557% % -52%
Debt-to-equity 64% % 127%
Return On Assets -111% % -78%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $30,100,000 USD -84%
Weighted Average Number of Shares Outstanding, Basic 5,954,405 shares 0.93%
Weighted Average Number of Shares Outstanding, Diluted 5,954,405 shares 0.93%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $34,921,000 USD -13%
Selling and Marketing Expense $2,719,000 USD -43%
General and Administrative Expense $18,107,000 USD -18%
Operating Income (Loss) $55,747,000 USD 17%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $53,593,000 USD 14%
Net Income (Loss) Attributable to Parent $53,593,000 USD 14%
Earnings Per Share, Basic 0 USD/shares 28%
Earnings Per Share, Diluted 0 USD/shares 28%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,164,000 USD -55%
Cash, Cash Equivalents, and Short-term Investments $13,414,000 USD -78%
Assets, Current $15,075,000 USD -76%
Property, Plant and Equipment, Net $3,475,000 USD -28%
Operating Lease, Right-of-Use Asset $9,822,000 USD -9%
Other Assets, Noncurrent $39,000 USD -56%
Assets $29,347,000 USD -64%
Accounts Payable, Current $915,000 USD -62%
Employee-related Liabilities, Current $728,000 USD -82%
Accrued Liabilities, Current $905,000 USD -82%
Liabilities, Current $3,176,000 USD -63%
Operating Lease, Liability, Noncurrent $11,530,000 USD -11%
Liabilities $15,259,000 USD -33%
Accumulated Other Comprehensive Income (Loss), Net of Tax $8,000 USD -94%
Retained Earnings (Accumulated Deficit) $235,602,000 USD -29%
Stockholders' Equity Attributable to Parent $14,088,000 USD -76%
Liabilities and Equity $29,347,000 USD -64%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $11,768,000 USD 19%
Net Cash Provided by (Used in) Financing Activities $17,000 USD 750%
Net Cash Provided by (Used in) Investing Activities $4,613,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,100,000 USD -49%
Deferred Tax Assets, Valuation Allowance $90,410,000 USD 24%
Deferred Tax Assets, Gross $93,269,000 USD 23%
Operating Lease, Liability $12,886,000 USD -8.4%
Depreciation $369,000 USD -29%
Payments to Acquire Property, Plant, and Equipment $5,000 USD -50%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $53,709,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid $16,956,000 USD -12%
Property, Plant and Equipment, Gross $10,086,000 USD 3%
Operating Lease, Liability, Current $1,356,000 USD 16%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,502,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,430,000 USD 3.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4,070,000 USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,574,000 USD 2.9%
Deferred Tax Assets, Operating Loss Carryforwards $44,436,000 USD 28%
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,646,000 USD 2.8%
Operating Lease, Payments $576,000 USD 3.2%
Additional Paid in Capital $249,665,000 USD 4.1%
Depreciation, Depletion and Amortization $352,000 USD -31%
Deferred Tax Assets, Net of Valuation Allowance $2,859,000 USD -8.7%
Share-based Payment Arrangement, Expense $2,049,000 USD -30%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%